TrialEuropean journal of heart failure2017

Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.

John R Teerlink et al.PubMed ↗Publisher ↗

No numbers read from the abstract.